Liquid Phase Peptide Synthesis Market - Top Companies and Manufacturers

  • Report ID: 3221
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Companies Dominating the Liquid Phase Peptide Synthesis Landscape

    • ©AAPPTec.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
    • CEM Corporation
    • Bachem AG
    • CSBio
    • Biotage
    • AnaSpec 
    • ZenBio, Inc
    • Thermo Fisher Scientific Inc. 
    • GenScript
    • PolyPeptide Group

Browse Key Market Insights with Data Illustration:

In the News

  • April 2022- The next generation of automated microwave peptide synthesizers, the Liberty 2.0 instrumentation line, has been released by CEM Corporation, with pride. The Liberty 2.0 series is a further advancement of CEM's highly acclaimed SPPS technology, yielding notable improvements in peptide purity, synthesis efficiency, and automation dependability.
  • August 2022- Peptides are well-liked active ingredients in cosmeceuticals, which are cosmetic products. Much research on the topic of dermatology has shown that peptides contribute to the maintenance of a youthful and healthy appearance. Because they can boost the formation of dermal extracellular matrix proteins like collagen, they are especially interesting for anti-aging applications. Additionally, studies have demonstrated that several peptides can encourage angiogenesis, cell migration, and wound healing.

Author Credits:  Radhika Pawar


  • Report ID: 3221
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of liquid phase peptide synthesis is estimated at USD 5.98 billion.

The liquid phase peptide synthesis market size was over USD 5.51 billion in 2024 and is poised to exceed USD 19.25 billion by 2037, witnessing over 10.1% CAGR during the forecast period i.e., between 2025-2037. Growing demand for peptide-based therapeutics, expanding applications, research and development, and supportive government policies will boost the market growth.

North America industry is predicted to dominate majority revenue share of 42% by 2037, fueled by robust research and development activities, the region witnesses extensive utilization of peptides in drug discovery and development by pharmaceutical giants and biotechnology firms.

The major players in the market are CEM Corporation, Bachem AG, CSBio, Biotage, AnaSpec, ZenBio, Inc., Thermo Fisher Scientific Inc., GenScript, PolyPeptide Group, Sosei Group Corporation, Tokyo Mirai Style Co., Ltd., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample